WO2026092739 - LINKER, LIGAND-DRUG CONJUGATE, AND PHARMACEUTICAL USE
National phase entry is expected:
Publication Number
WO/2026/092739
Publication Date
07.05.2026
International Application No.
PCT/CN2025/132223
International Filing Date
03.11.2025
Title **
[English]
LINKER, LIGAND-DRUG CONJUGATE, AND PHARMACEUTICAL USE
[French]
LIEUR, CONJUGUÉ LIGAND-MÉDICAMENT ET UTILISATION PHARMACEUTIQUE
[Chinese]
连接子、配体-药物偶联物及其医药用途
Applicants **
GAN & LEE PHARM CO LTD
Inventors
SUN, Yingjie
JIAO, Jiao
CUI, Menghan
WANG, Jiaxing
LI, Shuang
Priority Data
202411546060.3
01.11.2024
CN
202510633979.4
16.05.2025
CN
202510079398.0
17.01.2025
CN
202510118220.2
24.01.2025
CN
202510387359.7
31.03.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4027 | |
| EPO | Filing, Examination, Granting | 29062 | |
| Japan | Filing, Examination, Granting | 2893 | |
| South Korea | Filing, Examination, Granting | 3639 | |
| USA | Filing, Examination, Granting | 10090 |
Total:
49,711
Contact Us
Abstract[English]
Disclosed in the present invention are a new linker compound, a ligand-drug conjugate, a pharmaceutical composition containing the compound or the conjugate, and a corresponding pharmaceutical use.[French]
La présente invention concerne un nouveau composé lieur, un conjugué ligand-médicament, une composition pharmaceutique contenant le composé ou le conjugué, ainsi que l'utilisation pharmaceutique correspondante.[Chinese]
本发明公开了新的连接子化合物、配体-药物偶联物及包含所述化合物或偶联物的药物组合物、以及相应的医药用途。